Enviri Corp (NVRI) Q4 2025 Earnings Call Transcript

Why It Matters

The results underscore accelerating secular demand for nuclear power services and demonstrate Mirion’s ability to translate acquisitions and AI‑driven efficiencies into higher margins and cash generation, positioning the company for robust growth in a capital‑intensive sector.

Key Takeaways

• Record $1.1B orders, 26% YoY growth.
• Nuclear power now 40% of total revenue.
• Backlog up 36% after Paragon acquisition.
• Adjusted EBITDA margin expands 100 bps in 2025.
• AI applications launched improve productivity across verticals.

Pulse Analysis

The nuclear power market is entering a period of accelerated expansion as aging fleets require life‑extension upgrades and new builds, including small modular reactors (SMRs), gain traction. Mirion’s installed‑base model, which now generates roughly 80% of revenue, positions it to capture recurring modernization spend, while the company’s $400 million large‑project pipeline signals a pipeline of multi‑year contracts that can sustain top‑line momentum beyond 2026.

Strategic acquisitions of CertRec and Paragon have deepened Mirion’s footprint in North America, pushing nuclear‑power‑related revenue to about 40% of the company’s total. The integration of these assets is already delivering cost synergies, notably a near‑100‑basis‑point boost to adjusted EBITDA margins through procurement optimization. Parallel AI initiatives—17 internal applications launched in 2025—are enhancing operational efficiency and product innovation, further strengthening margin expansion prospects.

Financially, Mirion delivered a 7.5% revenue increase and doubled free‑cash‑flow conversion to 57% in 2025, underscoring disciplined capital management. The 2026 outlook projects 22‑24% revenue growth, driven by both organic demand and acquisition tailwinds, with adjusted EBITDA expected to reach $285‑$300 million and margins expanding to 25‑26%. Investors should note the reduced cost of debt, now 2.9%, and the company’s focus on scaling AI‑enabled services, which together provide a compelling growth narrative despite short‑term headwinds in the medical segment.